Skip to main content

An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis.

Hepburn S, Cairns DA, Jackson D, Craven RA, Riley B, Hutchinson M, Wood S, Smith MW, Thompson D, Banks RE

Publication: Proteomics Clin Appl (2015) • Vol 9 • Page 507-21PMID: 25400092View on PubMed

Purpose

This paper investigated the effects of addition of protease inhibitors (PI) and processing delays on the SELDI-TOF MS spectra and 2D-gel analysis of urine.

Conclusion

The biggest determinant of the MS-spectra was interpatient variability, but clear effects of the addition of PI were observed for 3 of 10 patients. While 30.7% of peaks for one patient were affected by storage for 6 h at room temperature compared to immediately processed specimens, only 1.2% of peaks were altered in specimens from four other patients. Similarly, the largest differences in 2D-gels were attributable to interpatient variability with small effects of processing delay or PI observed in some patients. Finally, levels of β2-microglobulin (B2M), α1-microglobulin (α1M), immunoglobulin G (IgG), and albumin differed among patients but were not consistently affected by processing delay or PI.

Studies (1)

Purpose

This study investigated the effects of addition of protease inhibitors and processing delays on the SELDI-TOF MS spectra and 2D-gel analysis of urine. Midstream urine specimens were collected from five patients 8-29 days post-renal transplant, three patients with kidney stones, and two patients with recurring urinary tract infections (UTIs). Urine was immediately analyzed for blood and protein using dipsticks and for protein and creatinine using an autoanalyzer. The pH was then adjusted to 7.0 and the specimens were aliquoted. Protease inhibitors were added to half of the aliquots. Aliquots were centrifuged at 2000 × g for 10 min immediately or after 6 h of storage at either room temperature or 4˚C and the supernatants were frozen at -80˚C.  Urine was thawed at room temperature, concentrated using an Amicon 10 kDa MWCO Ultra-15 filter, and resuspended in DIGE lysis buffer. The peptide profile was determined by SELDI-TOF-MS using an IMAC30-Cu ProteinChip array and by 2D-PAGE. Levels of proteins, β2-microglobulin (B2M), α1-microglobulin (α1M), IgG, and albumin were determined using autoanalyzers.

Summary of Findings

A total of 228 peaks were detected but those identified differed among the patients and the average number of peaks per individual ranged from 156-211. Cluster analysis revealed that specimens clustered predominantly by patient with some clustering by diagnosis and clustering by PI status was observed in specimens from 3 of 10 patients. Interestingly, in one of the patients with perfect clustering based on PI status, all of the changes were less than 2-fold. Although there was no evident clustering based on pre-centrifugation storage in one patient, 30.7% of peaks were found to have changed more than 2-fold when specimens were stored for 6 h at room temperature compared to those that were immediately processed with protease inhibitors.  In contrast, only 1.2% of peaks were altered after processing delays in four patients. While most effects were inconsistent among patients, there were several peaks in the region of 6000–6600 m/z that were increased when protease inhibitors were present.  In the absence of PI, immediate processing prevented the decrease in some of these peaks.

A mean of 1082 spots were detected by 2D-PAGE. Although the profiles were similar between patients overall, there were a lot of differences in the moderate to low abundant spots. When specimens from six patients were considered, 849 of 855 spots detected differed significantly among the patients. Consequently, interpatient variation made it impossible to observe any effect of PI or processing delays. Principal component analysis (PCA) of individual patient’s specimens showed no evidence of an effect of PI and what effects of processing delay depended on patient and temperature.

Although levels of B2M, α1M, IgG, and albumin differed significantly among patients they were not significantly affected by the addition of PI or processing delays.

  • Biospecimens

    FluidUrine
  • Preservation Types

    Frozen
  • Diagnoses

    Other diagnoses
  • Platforms

    PeptideSELDI-TOF MS
    ProteinSELDI-TOF MS
    Protein1D/2D gels
    Peptide1D/2D gels
    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    StorageStorage duration
    0 h
    6 h
    StorageStorage temperature
    4˚C
    Room temperature
    Analyte Extraction and PurificationProtease inhibitor
    Added before storage
    No protease inhibitor added